Search research articles
Contact Us
Filters
Showing results (371-380 of 386) with videos related to
Page
of 39
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 10, 2022
Clinical Models to Define Response and Survival With Anti-PD-1 Antibodies Alone or Combined With Ipilimumab in Metastatic Melanoma
Inês Pires da Silva, Tasnia Ahmed, Jennifer L McQuade, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 26, 2024
Outcomes of patients with resected stage III/IV acral or mucosal melanoma, treated with adjuvant anti-PD-1 based therapy
Sarah K Jacques, Janet McKeown, Piyush Grover, et al.
The Lancet. Digital Health
|
September 29, 2023
Comparison of humans versus mobile phone-powered artificial intelligence for the diagnosis and management of pigmented skin cancer in secondary care: a multicentre, prospective, diagnostic, clinical trial
Scott W Menzies, Christoph Sinz, Michelle Menzies, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 21, 2021
Pathological response and tumour bed histopathological features correlate with survival following neoadjuvant immunotherapy in stage III melanoma
R V Rawson, C Adhikari, C Bierman, et al.
Cancer
|
November 10, 2024
A comparison of isolated limb infusion/perfusion, immune checkpoint inhibitors, and intralesional therapy as first-line treatment for patients with melanoma in-transit metastases
Danielle K DePalo, Michelle M Dugan, Syeda Mahrukh Hussnain Naqvi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 3, 2025
Pathological response calculation assessment remains accurate with reduced tumor bed examination after neoadjuvant immunotherapy in clinically detectable stage III melanoma
R V Rawson, N G Maher, A M Menzies, et al.
The Medical Journal of Australia
|
May 2, 2021
Australia in 2030: what is our path to health for all?
Kathryn Backholer, Fran Baum, Summer M Finlay, et al.
Cancer Discovery
|
September 13, 2022
Comparative Genomics Provides Etiologic and Biological Insight into Melanoma Subtypes
Felicity Newell, Peter A Johansson, James S Wilmott, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 24, 2021
Chemotherapy after immune checkpoint inhibitor failure in metastatic melanoma: a retrospective multicentre analysis
Simone M Goldinger, Kristina Buder-Bakhaya, Serigne N Lo, et al.
JAMA Dermatology
|
April 9, 2025
Global Applicability of a Risk Prediction Tool for Sentinel Node Positivity in Patients With Primary Cutaneous Melanoma
Serigne N Lo, Caroline Gjorup, Annette Hougaard Chakera, et al.
Page
of 39
Search research articles
Search
Showing results (371-380 of 386) with videos related to
Sort By:
Page
of 39
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 10, 2022
Clinical Models to Define Response and Survival With Anti-PD-1 Antibodies Alone or Combined With Ipilimumab in Metastatic Melanoma
Inês Pires da Silva, Tasnia Ahmed, Jennifer L McQuade, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 26, 2024
Outcomes of patients with resected stage III/IV acral or mucosal melanoma, treated with adjuvant anti-PD-1 based therapy
Sarah K Jacques, Janet McKeown, Piyush Grover, et al.
The Lancet. Digital Health
|
September 29, 2023
Comparison of humans versus mobile phone-powered artificial intelligence for the diagnosis and management of pigmented skin cancer in secondary care: a multicentre, prospective, diagnostic, clinical trial
Scott W Menzies, Christoph Sinz, Michelle Menzies, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 21, 2021
Pathological response and tumour bed histopathological features correlate with survival following neoadjuvant immunotherapy in stage III melanoma
R V Rawson, C Adhikari, C Bierman, et al.
Cancer
|
November 10, 2024
A comparison of isolated limb infusion/perfusion, immune checkpoint inhibitors, and intralesional therapy as first-line treatment for patients with melanoma in-transit metastases
Danielle K DePalo, Michelle M Dugan, Syeda Mahrukh Hussnain Naqvi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 3, 2025
Pathological response calculation assessment remains accurate with reduced tumor bed examination after neoadjuvant immunotherapy in clinically detectable stage III melanoma
R V Rawson, N G Maher, A M Menzies, et al.
The Medical Journal of Australia
|
May 2, 2021
Australia in 2030: what is our path to health for all?
Kathryn Backholer, Fran Baum, Summer M Finlay, et al.
Cancer Discovery
|
September 13, 2022
Comparative Genomics Provides Etiologic and Biological Insight into Melanoma Subtypes
Felicity Newell, Peter A Johansson, James S Wilmott, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 24, 2021
Chemotherapy after immune checkpoint inhibitor failure in metastatic melanoma: a retrospective multicentre analysis
Simone M Goldinger, Kristina Buder-Bakhaya, Serigne N Lo, et al.
JAMA Dermatology
|
April 9, 2025
Global Applicability of a Risk Prediction Tool for Sentinel Node Positivity in Patients With Primary Cutaneous Melanoma
Serigne N Lo, Caroline Gjorup, Annette Hougaard Chakera, et al.
Page
of 39